Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis

Figure 10

Enrichment analysis of high- and low-risk groups: (a) analysis of pathway enrichment in high- and low-risk groups; (b) analysis of functional enrichment in high- and low-risk groups.

(a)

(b)